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relaxation, however, the downward-shift of coronary pressure-flow relation-
ship can be blunted by the reduced myocardial contractile force against the
coronary resistance vessels.
Thus, in ischemic HF, baseline flow is decreased and coronary vascular re-
serve is markedly decreased in remote, non-infarct vessels of the heart. This
may contribute importantly to the progression of left ventricular dysfunction
even at remote areas.
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1745-1 I Management and Long-term Outcome of Patients
with Electrical Storm
Koonlawee Nademanee, Richard D. Taylor, William M. Bailey. Denver General
Hospital and University of Colorado, Denver, CO
Patients with recent MI may develop recurrent cardiac arrest due to polymor-
phic VTNF > 20 episodes a day; electrical storm (ES). ES usually portends
a grave outcome; the treatment of ES remains a dilemma, and physicians
often resort to intravenous antiarrhythmics (AA) (lidocaine, procainamide,
bretylium, or a combination of these), as outlined in the ACLS guidelines.
Since ES is associated with increased sympathetic activity, we hypothesized
that sympathetic blockade (SB) would benefit ES patients. Thus, we com-
pared the outcome of treatment between SB and AA in 34 consecutive pa-
tients with ES. All (30 M, 4 F; mean age 58) had recent MI, but the index VTNF
occurred at least 2 days after the onset of MI; 22 had anterior MI, 9 inferior,
and 3 both anterior and inferior. All had sinus tachycardia or supraventricu-
lar arrhythmias, but had normal aT (mean aT 0.3B ± 0.05). 16 patients (Gr.
I) were treated with AA and 18 (Gr. II) were treated with SB (7 left stellate
ganglionic blockade and 11 ,II-blockade [7 IV propranolol; 2 IV sotalol and
2 esmolol]). Both Gr. I and II had comparable clinical characteristics. Mean
EF was 31 % in Gr. I and 30% in Gr. II. The above figure shows that 90%
of Gr. I patients died within the first 10 days due to VTNF (mean 32 ± 12
episodes/day). compared to only 18% deaths and near abolition of VTNF in
Gr. II. At one year follow-up, all Gr. I patients eventually died, but Gr. II had an
excellent outcome; 13 of 18 were alive and well (72%). Gr. I had a 6 times
greater relative risk of death than did Gr. II (p < 0.05). Conclusions: 1) ES in
patients with recent MI should be treated with SB. 2) AA as recommended
by ACLS for multiple cardiac arrests are ineffective in ES.
Age (mean ± SD years)
Histologic cell type
Lymphocytic myocarditis, N, (percent) 16(73)
Granulomatous myocarditis, N, (percent) 6(271
Mean LV end-diastolic pressure ImmHg) 15 ± 7
Mean NYHA heart failure class 1.7 ± 1
Any atrioventricular block, N, (percent) 10(45)
Intraventricular conduction defect, N, (percent) 13 (60)
Mean aT duration (milliseconds) 426 ± 66
Mean OTc duration (milliseconds) 456 ± 44
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1745-21 Sustained Ventricular Tachycardia or Cardiac Arrest
as the Initial Manifestation of Myocarditis: Relation-
ship to Clinical Variables and Histologic Findings
Michael O. Sweeney, Jeremy Ruskin, Brian McGovern, Hasan Garan, G.
William Dec. Massachusetts General Hospital, Boston, MA
Myocarditis was histologically confirmed by biopsy in 102 pts during a 19
year period. Twenty-two pts (22%) presented with sustained ventricular tach-
yarrhythmias (SUSVT; monomorphic ventricular tachycardia N = 14, cardiac
arrest N = 8). Of the remaining 80 pts (OTHER), 60 (59%) presented as heart
failure, 12 (11 %) as myocardial infarction and 8 (8%) as atrioventricular block.
There were no differences between SUSVT and OTHER in: gender, atrial ar-
rhythmias, right atrial or pulmonary capillary wedge pressure, cardiac index,
ejection fraction, or left ventricular wall motion abnormalities. The following
variables differed between groups:
ET 100 nM
89.6 ± 7.2
40.9 ± 88'
912 ± 5.8
78.3 ± 7.2
32.4 ± 112'
ET 10 nM
28.9 ± 95
8.3 ± 2.7*
28.5 ± 3.3
31.2 ± 45
6.1 ± 2.5'
ET 1 nM
12.0 ± 37
3.2 ± 1.7'
10.6 ± 2.8
9.7 ± 1.9
1.8 ± 1.2'
Before heart failure After heart failure
Occ. 10 261.7 ± 10% 131.6±69%
(sec) 15 250.7 ± 6% 102.8 ± 63%
30 240.4 ± 8% 96.4 ± 68%
Ach 025 74.4 ± 7% 19.4 ± 14%
(/tglkg) 5 162.1 ± 29% 41.7 ± 22%
10 144.4 ± 6% 662 ± 31%
ADO 0.25 114±25% 36.7 ± 32%
(/tMollkg) 2 202.3 ± 36% 47.2 ± 49%
5 206.9 ± 46% 41.8±71%
Group
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1744-51 Ischemic Heart Failure is Associated with Reduced
Blood Flow Reserve in Non-embolized Arteries in
Awake Dogs
Mathias Knecht, Sulli Popilskis, Geng-Hua Yi, Milton Packer, Daniel Burkhoff,
Jie Wang. Columbia-Presbyterian Medical Center, New York City, New York
With coronary obstruction, as in myocardial infarction, there is increased re-
liance on collateral blood flow from remote arteries. However, it remains un-
known whether, with the development of heart failure (HF) consequent to
the infarction, there are changes in the physiology of the remote vessels
which may modify their ability to provide collateral flow. The goal of this
study was to determine vasodilator capacity in non-embolized coronary vas-
culature in ischemic HF. Dogs were chronically instrumented to measure sys-
temic hemodynamics. A catheter was implanted into a dominant coronary
artery for multiple embolizations and a Doppler flow probe was placed on a
non-catheterized coronary artery for measurements of coronary blood flow
(CBF). HF was produced by repeated coronary embolizations and character-
ized by elevated left ventricular (LV) end-diastolic pressure and reduction in
maximum LVdp/dt as well as clinical signs of HF. CBF at rest was 24 ± 0.4
mlfmin vs 17 ± 1 mlfmin before and after HF. The peak CBF responses follow-
ing release of a brief coronary artery occlusion (Occ), to acetylcholine IAch)
and to adenosine (ADO) were examined before and after HF. The % changes
of CBF from baseline are:
Sham
Septic
Sham + NMA
Septic + NMA
Septic + NMA + L-arginine
'p < 0.05 compared to Sham and Septic + NMA groups. n ~ 8 ratslgroup
Vascoconstriction in response to ET in resistance arterioles in vivo was
decreased in septic rats compared to sham controls. Taken together with
similar results using norepinephrine in this model, these findings suggest
a generalized abnormality in vasoconstrictor responsiveness of resistance
arterioles in sepsis. Vascular responsiveness to ET in septic rats was restored
by NOS inhibition, and the effect was reversed with superfusion of excess
(1 mM) L-arginine. These studies suggest that nitric oxide may represent
the common mechanism of the refractory vasodilation seen in patients with
septic shock.
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1744-61 Impaired Arteriolar Responsiveness to Endothelin-1
in Septic Rats is Reversed by NG-Methyl-L-Arginine
Steven M. Hollenberg, Mark J. Piotrowski, Joseph E. Parrillo. Section of Cardiology.
Rush-Presbyterian-St. Luke's Medical Center, Chicago,IL
Persistent vasodilation refractory to pressor agents is a characteristic hemo-
dynamic abnormality in septic shock. Induction of nitric oxide synthase INOS)
by cytokines has been hypothesized to playa role in this refractory vasodila-
tion. To investigate this pathogenetic mechanism, we used in vivo videomi-
croscopy to measure responses of resistance arterioles (15-20 I'm) to top-
ical suffusion of the endogenous vasoconstrictor, endothelin-l (ET). Rats
made septic by cecal ligation and puncture were compared to controls that
underwent sham ligation. Responses to topically suffused ET were assessed
in rat cremaster muscle of septic and control rats before and after superfu-
sion of the muscle with the NOS inhibitor NG- -methyl-L-arginine (NMA).
Arteriolar Vasoconstriction (% maximal contraction)
